from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2780/ald

LFCtreatmentdescriptionclass of inhibitor

0.637

Amikacinug/mL Amikacintranslation

0.166

Cap5-10ug/mL Capreomycintranslation

1.016

Rox10-50 ug/mL Roxithromycintranslation

0.240

SM2-5 ug/mL Streptomycintranslation

0.882

Tet5-10 ug/mL Tetracyclinetranslation

-0.554

Rif0.2-5ug/mL Rifampicintranscription

-0.171

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.574

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.655

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.206

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.773

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.643

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.480

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.065

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.945

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.599

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.521

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.362

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.464

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.581

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.006

KCN5-20 ug/mL Potassium cyaniderespiration

-0.623

NaN30.2-2 mM Sodium aziderespiration

0.771

Nigericin50 uM Nigericinrespiration

1.450

TRC10-150 ug/mL Triclosanrespiration

0.219

TRZ10-25 ug/mL Thioridazinerespiration

-0.296

Valinomycin0.5-10 uM Valinomycinrespiration

-0.854

ZnSO42 mM ZnSO4respiration

-0.888

menadione6-10 ug/mL Menadionerespiration

-0.912

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.448

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.577

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.349

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.405

NRP_1Non-replicating persistence stage 1dosRassociated

-0.354

Amp0.2mg/mL AmpicillincellWall

-0.474

Cephalexin20-100 ug/mL CephalexincellWall

-0.482

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.389

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.492

EMB10-20 ug/mL EthambutolcellWall

-0.448

Eta12-40 ug/mL EthionamidecellWall

-0.702

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.736

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.951

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.065

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.928

BZA0.12 mg/mL BenzamidearomaticAmides

1.749

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.465

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.534

H2O24 mM hydrogen peroxideDNAdamaging

-0.638

Levo10 ug/mL LevofloxacinDNAdamaging

-0.637

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.369

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.618

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.626

UVUV-irradiationDNAdamaging

1.029

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.719

Antimycin12.5-50 ug/mL Antimycin A?

-0.322

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.755

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.488

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.678

PA8240.2-2 ug/mL PA-824?

-0.215

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.809

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.600

Verapamil50 uM Verapamil?

-0.223

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.262

methoxatin10-20 ug/mL Methoxatin?